Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Cabral Sells 10,721 Doximity Shares Under 10b5-1 Plan

Director Timothy S. Cabral filed a Form 4 with the SEC on November 9, 2026, reporting transactions in Doximity, Inc. (NYSE:DOCS) Class A and Class B Common Stock dated November 5, 2026.

Anjali Anand | 09 November 2026

Schulze Gains 435 Shares via Spouse Trustee Appointment

Richard M. Schulze, Chairman Emeritus of Best Buy Co Inc, filed a Form 4 on November 9, 2026, disclosing a change in beneficial ownership of common stock resulting from the appointment of his spouse as trustee of a trust on November 5, 2026.

Nitish Kishor | 09 November 2026

Teladoc's Nueno Sells 29,432 Shares at $9.20

Carlos Nueno, President, International at Teladoc Health, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 29,432 shares of common stock on November 6, 2026, under a pre-established Rule 10b5-1 trading plan.

Aakashdeep | 09 November 2026

Edgar R. Smith III Buys 5,000 FGBI Shares at $11.80

Director and 10% owner Edgar R. Smith III filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 5,000 shares of First Guaranty Bancshares, Inc. common stock on November 6, 2026.

Nitish Kishor | 09 November 2026

Director Beth Bruce Witte Sells 25,000 Slide Insurance Shares

A Form 4 filed on November 9, 2026 reports that Beth Bruce Witte, a director of Slide Insurance Holdings, Inc. (NASDAQ:SLDE), sold 25,000 shares of common stock on November 5, 2026 through the Beth W. Bruce Witte Family 1992 Trust.

Manish Choudhary | 09 November 2026

Moderna COO Juan Receives Options and RSUs on Nov 5, 2026

Juan Andres, Chief Operating Officer of Moderna, Inc., filed a Form 4 on November 9, 2026, disclosing the acquisition of stock options and restricted stock units on November 5, 2026 under NASDAQ:MRNA.

Aakashdeep | 09 November 2026

Joel Ackerman Gets 31,216 Options at $4.76 from Champions Oncology

Director Joel Ackerman of Champions Oncology, Inc. filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of options to purchase 31,216 shares of common stock on November 5, 2026.

Shwetambri Chauhan | 09 November 2026

Carl Russo Sells 75,000 Calix Shares on Nov. 6, 2026

Carl Russo, a director and 10% owner of Calix, Inc. (NYSE:CALX), filed a Form 4 on November 9, 2026, disclosing the sale of 75,000 shares of common stock on November 6, 2026, pursuant to a Rule 10b5-1 trading plan.

Nitish Kishor | 09 November 2026

Scott Tobin Gets 37,460 Options at $4.76 from Champions Oncology

Director and 10% owner Scott R. Tobin filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of stock options to purchase common stock of Champions Oncology, Inc. (NASDAQ:CSBR), with the earliest transaction date of November 5, 2026.

Aditi Sarkar | 09 November 2026

Mendelson Receives 20,291 Options at $4.76 from Champions Oncology

Director Daniel Newman Mendelson filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of options to purchase common stock of Champions Oncology, Inc. (NASDAQ:CSBR), with the earliest transaction date of November 5, 2026.

Aditi Sarkar | 09 November 2026
Support

Hi! How can we help you today?

Loading…